Immunization News and Research

RSS

Researchers receive $100,000 grant for new project on community health workers

For Department of Kinesiology and Community Health researchers Andiara Schwingel and Susan Aguiñaga, the concept of helping place Community Health Workers has a personal meaning.

9 Dec 2021

Long term vaccine response following Pfizer COVID-19 vaccination in hemodialysis patients

Researchers discuss the long-term humoral immune responses in hemodialysis patients after being vaccinated with the BNT162b2 mRNA vaccine.

9 Dec 2021

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

A review article focuses on the efficacy of neutralizing antibodies and vaccines against the SARS-CoV-2 variants.

9 Dec 2021

Increased risk of COVID-19 breakthrough infections in fully vaccinated people with HIV

New study results showed a 41% greater incidence of breakthrough infections in people with HIV compared to that of people without HIV.

9 Dec 2021

For most young people, COVID vaccine-related myocarditis is not serious

A new study published in the journal Circulation aimed to describe a large case series of suspected myocarditis temporally related with the COVID-19 vaccine in adolescents and young adults below 21 years of age across the United States and Canada.

8 Dec 2021

Neutralization antibodies elevated in nursing home residents after COVID-19 mRNA boosters

Researchers from the United States, in their recent study published on the preprint server medRxiv*, have evaluated the humoral responses to third vaccine dose in nursing home residents and healthcare workers (HCW) and found that that second booster (or third vaccine dose) significantly increased anti-spike, anti-receptor binding domain (RBD), and neutralization titers in almost all nursing home residents and HCW to considerably higher levels than what was attained after the completion of the initial two-dose vaccine series.

8 Dec 2021

WHO welcomes Gavi Alliance Board's historic decision to invest in first malaria vaccine

WHO welcomes the historic decision by the Gavi Alliance Board to invest in the first malaria vaccine programme.

8 Dec 2021

Routine immunization coverage declined in first year of COVID

A new study published on the medRxiv* preprint server investigated changes in RI coverage using two key indicators – diphtheria-tetanus-pertussis first-dose (DTP1) and third-dose (DTP3). DTP3 serves as a general marker for immunization system performance, while DTP1 is used as a proxy for inequity - quantifying Zero Dose (ZD) children––those that receive no childhood vaccinations

8 Dec 2021

Homologous mRNA and heterologous vaccines elicit high immune responses

New study findings show that homologous mRNA or heterologous vaccination induces the highest immune responses due to high RBD- and S1-specific antibodies.

7 Dec 2021

Comparison of waning COVID-19 immunity between vaccinated and infected individuals

The current study compares the waning of immunity in infected-and-recovered vs. vaccinated cohorts.

7 Dec 2021

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.

6 Dec 2021

SARS-CoV-2 S2 immunization as a pan-coronavirus vaccine approach

A new mouse model suggests that prior HCoV-OC43 S immunity primes neutralising antibody responses to otherwise subimmunogenic SARS-CoV-2 S exposure as well as promotes S2-targeting antibody responses.

6 Dec 2021

Study shows COVID booster shots work

A new study investigates uses seven different COVID-19 vaccines as the third dose to boost immunity in vulnerable patients.

6 Dec 2021

SARS-CoV-2 virus-like particles elicit potent neutralizing antibody response in variant challenge

Researchers develop a virus-like particle for SARS-CoV-2 based on the co-expression of the spike, membrane, and envelope structural proteins.

6 Dec 2021

Most young people improve quickly from COVID-19 vaccine-related myocarditis

Most young people under the age of 21 who developed suspected COVID-19 vaccine-related heart muscle inflammation known as myocarditis had mild symptoms that improved quickly, according to new research published today in the American Heart Association's flagship journal Circulation.

6 Dec 2021

Publicly funded school-based programs can help improve HPV vaccine uptake in children

Boys are 10 times more likely to be vaccinated against human papillomavirus (HPV) in provinces where the vaccine is publicly funded than in places where it is not, according to a new study published by a researcher at the Princess Margaret Cancer Centre and colleagues at McGill University, Université de Montréal, and the Jewish General Hospital.

6 Dec 2021

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Researchers have presented the results of phase 1 and phase 2 clinical trials of a SARS-CoV-2 recombinant spike protein vaccine (Abdala).

6 Dec 2021

SARS-CoV-2 immune memory in mRNA vaccine recipients

Researchers measured SARS-CoV-2–specific antibody, memory B cell, and memory T cell responses in a group of healthy subjects who generated primary immune responses to two doses of mRNA vaccine compared to a group of SARS-CoV-2–recovered vaccines.

6 Dec 2021

The emergence and evolution of SARS-CoV-2 and its VOCs

A review article discusses the evolution of SARS-CoV-2 and the emergence of variants of concern.

5 Dec 2021

Minister for Equalities calls for everyone to get COVID-19 jabs

The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.

3 Dec 2021

Immunization News and Research

Researchers receive $100,000 grant for new project on community health workers

Long term vaccine response following Pfizer COVID-19 vaccination in hemodialysis patients

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Increased risk of COVID-19 breakthrough infections in fully vaccinated people with HIV

For most young people, COVID vaccine-related myocarditis is not serious

Neutralization antibodies elevated in nursing home residents after COVID-19 mRNA boosters

WHO welcomes Gavi Alliance Board's historic decision to invest in first malaria vaccine

Routine immunization coverage declined in first year of COVID

Homologous mRNA and heterologous vaccines elicit high immune responses

Comparison of waning COVID-19 immunity between vaccinated and infected individuals

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

SARS-CoV-2 S2 immunization as a pan-coronavirus vaccine approach

Study shows COVID booster shots work

SARS-CoV-2 virus-like particles elicit potent neutralizing antibody response in variant challenge

Most young people improve quickly from COVID-19 vaccine-related myocarditis

Publicly funded school-based programs can help improve HPV vaccine uptake in children

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

SARS-CoV-2 immune memory in mRNA vaccine recipients

The emergence and evolution of SARS-CoV-2 and its VOCs

Minister for Equalities calls for everyone to get COVID-19 jabs

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News